- Home
- ZYXI vs ICCM Comparison
ZYXI vs ICCM Comparison
Compare ZYXI & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- ICCM
- Stock Information
- Founded
- ZYXI 1996
- ICCM 2006
- Country
- ZYXI United States
- ICCM Israel
- Employees
- ZYXI N/A
- ICCM N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ICCM
- Sector
- ZYXI Health Care
- ICCM
- Exchange
- ZYXI Nasdaq
- ICCM Nasdaq
- Market Cap
- ZYXI 66.5M
- ICCM 70.1M
- IPO Year
- ZYXI N/A
- ICCM N/A
- Fundamental
- Price
- ZYXI $2.07
- ICCM $1.03
- Analyst Decision
- ZYXI Buy
- ICCM Strong Buy
- Analyst Count
- ZYXI 3
- ICCM 1
- Target Price
- ZYXI $6.00
- ICCM $2.50
- AVG Volume (30 Days)
- ZYXI 229.1K
- ICCM 199.2K
- Earning Date
- ZYXI 04-29-2025
- ICCM 05-27-2025
- Dividend Yield
- ZYXI N/A
- ICCM N/A
- EPS Growth
- ZYXI N/A
- ICCM N/A
- EPS
- ZYXI N/A
- ICCM N/A
- Revenue
- ZYXI $172,401,000.00
- ICCM $3,291,000.00
- Revenue This Year
- ZYXI N/A
- ICCM $97.02
- Revenue Next Year
- ZYXI $23.16
- ICCM $212.86
- P/E Ratio
- ZYXI N/A
- ICCM N/A
- Revenue Growth
- ZYXI N/A
- ICCM 1.92
- 52 Week Low
- ZYXI $1.66
- ICCM $0.48
- 52 Week High
- ZYXI $11.15
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- ZYXI 40.51
- ICCM 37.29
- Support Level
- ZYXI $1.95
- ICCM $1.00
- Resistance Level
- ZYXI $2.19
- ICCM $1.10
- Average True Range (ATR)
- ZYXI 0.21
- ICCM 0.08
- MACD
- ZYXI 0.08
- ICCM -0.01
- Stochastic Oscillator
- ZYXI 45.05
- ICCM 8.82
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.